- Home
- GCBC vs AQST Comparison
GCBC vs AQST Comparison
Compare GCBC & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GCBC | AQST |
|---|---|---|
| Founded | 1889 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 569.0M | 529.4M |
| IPO Year | 1998 | 2007 |
Fundamental Metrics
Financial Performance| Metric | GCBC | AQST |
|---|---|---|
| Price | $34.85 | $4.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 30.0K | ★ 2.3M |
| Earning Date | 04-22-2026 | 05-01-2026 |
| Dividend Yield | ★ 1.66% | N/A |
| EPS Growth | ★ 31.69 | N/A |
| EPS | ★ 2.41 | N/A |
| Revenue | $4,117,000.00 | ★ $67,430,000.00 |
| Revenue This Year | N/A | $10.08 |
| Revenue Next Year | N/A | $49.60 |
| P/E Ratio | $14.40 | ★ N/A |
| Revenue Growth | ★ 11.06 | 0.77 |
| 52 Week Low | $21.25 | $2.94 |
| 52 Week High | $36.33 | $7.55 |
Technical Indicators
Market Signals| Indicator | GCBC | AQST |
|---|---|---|
| Relative Strength Index (RSI) | 47.12 | 47.56 |
| Support Level | $33.84 | $4.51 |
| Resistance Level | $35.84 | $5.10 |
| Average True Range (ATR) | 0.84 | 0.26 |
| MACD | -0.15 | -0.06 |
| Stochastic Oscillator | 18.20 | 20.41 |
Price Performance
Historical ComparisonAbout GCBC Greene County Bancorp Inc.
Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.